Welcome to my nightmare, this is one of the most confusing one day charts I have looked at in quite a while. From afar, the larger counts look like a 4th wave, but the micro count is a REAL mess, almost like an on going "B", or "X" wave, the triangle I have labeled as a-b-c-d-e, breaks the first rule, wave "A", is a five count, we need a 3-3-3-3-3 count for the triangle to be valid.
A simple zig-zag is still possible, but wave "C" needs to be the largest for that count to work.
The other possibility is that we have had a top put in, I have seen numerous counts in the last 24 hours that have a five wave count completed, the micro-counts in them might be off, but at this point I am keeping that option on the table until the impulse count from 1037.63 is invalidated.
One other option, which I had a chart up of yesterday on my public list, is this whole rally counting out as an a-b-c-x-a-b-c, making wave b of B, of P2, an expanding triangle with the a of B ending at 979. This could really surprise the bears if we start heading down to make new lows, then quickly reverse in wave "C" up.
See Michael’s longer term chart (below) for the bigger picture:
Michael: P stands for primary wave. As soon as P2 ends, we will be in P3, down. P2 is the wave from 666 to the present, P1 was the wave from late ’07, till this year when it finished at 666. Ilene, I am very-very bearish, as soon as this rally is over we will be testing the lows of the year, and even quite possibily breaking them, wave 3′s are the mother of all waves, very violent and swift.
Not sure if that is any better then Monday morning quarterbacking. I brought this one out of my vault of super-secret and private stash of charts that only Anchak has laid eyes on. This one came about from the both of us playing with different indicators and tweaking them to get the most out of them. The one that caught my eye this morning was the RSI, adjusted just right, it has been a good and reliable indicator for showing trend changes in the SPX, by following the changes of trends in itself. Unbelievable how over-bought it has gotten in the last month, and now showing a definite trend change to the down side. When you couple the RSI with the MACD, and the Histogram, things are starting to point to a change coming soon, if it has not already changed. The Histogram has been in a negative divergence for the last month, and has its first red shoot, breaking below zero last week, while at the same time the MACD has also turned to the downside and crossed over, peaking last week. The MACD, a lagging indicator (used together with the histogram it can be used as a leading indicator) also showing a change is taking place. I am not ready to officially call that the top, I will leave it to you to make your own decisions. I am just sharing my Sunday morning thoughts with you. Hope you are enjoying your week-end!!
PS.-I moved this chart to the public list if you are interested in following it
I wanted to do a quick update and highlight the 60-minute SP500 intraday chart from the March lows to the June highs and overlay four Fibonacci grids over this move to uncover the hidden confluence zones. Doing so allows us to see why the recent break beneath 880 is perhaps very significant.
(Click image for full-size graph)
Without getting too complex, I’ve drawn four Fibonacci Retracement grids from the March lows to the June 11th highs using the classic methods.
I’m using the standard 38.2%, 50.0%, and 61.8% retracements, but also adding the lesser-known 23.6% and 78.6% retracements as well. I drew vertical lines to show where the grids originated.
The main point is that three of the four grids ‘converge’ at the 890 level (I’ve highlighted it). Notice how this area provided very strong support (in fact, it helped create the current “Head and Shoulders” since May.
Experience is never limited, and it is never complete; it is an immense sensibility, a kind of huge spider-web of the finest silken threads suspended in the chamber of consciousness, and catching every air-borne particle in its tissue.
The 120-minute SPX chart above shows a clustering of Wave 5′s (various degrees), followed by a breakdown of the Up-Trend Regression Channels and a Blue Wave Sell Signal, all taking place since last’s Thursday’s close.
The above chart the SPX pans out to the Daily perspective and reveals a rounding top that is just barely holding onto an 11-day-old Blue Wave Buy Signal that did flip to Short on an Intraday basis today, before those mysterious institutional buy programs again propped up a weakening close.
Finally, the above is a Weekly chart that is about as long in the tooth as it can be.
I want that Weekly trend regression channel broken to the downside and/or a Blue Wave Sell Signal before committing a total and immense sensibility to the Short sideof this market.
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
The head of the Center for Infectious Disease Research and Policy at the University of Minnesota – Dr. Michael Osterholm – is one of the world’s top infectious disease experts and a prominent public health scientist.
Dr. Osterholm just gave a talk shown on C-Span, explaining how to prevent the public from panicking about Ebola:
I categorically reject the idea that you can’t tell people you “don’t know” … because you’re afraid you’ll scare them.
There is a complete [scientific] literature on risk communications that says people are never frightened if you tell them you don’t ...
What do falling energy prices mean for the US consumer? Sober Look writes a brief yet thorough overview of the consequences of the correction in the price of crude oil. There are good aspects, particularly for the consumer, bad aspects, and out-right ugly possibilities. For more on this subject, read James Hamilton's How will Saudi Arabia respond to lower oil prices? In previous eras, Saudi Arabia would tighten the supply to help increase prices, but in this "game of chicken," the rules m...
The world market selloff moderated over the past week, except for Japan's Nikkei 225. The top performer in my gang of eight world indexes (and the sole gainer) was Germany's DAX, which rose 0.70%. At the bottom of the heap, the Nikkei plunged 5.02%. The S&P 500, like most of the others on the list, posted its 4th weekly loss, down 1.02%
Despite its 10.64% year-to-date advance, the Shanghai Composite remains the only index on the watch list in bear territory -- the traditional designation for a 20% decline from an interim high. The index is down 32.56% from its August 2009 peak. See the table inset (lower right) in the chart below.
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
Volatility continues to increase in the stock market and many of the leaders are breaking down. In particular, semiconductors took a rather big hit when one of the bellwethers warned of weakening global demand. Nevertheless, despite the significant headwinds, I do not think this spells the end of the bull market. But the technical damage to the charts is severe, particularly to the small caps, which are in full-blown correction mode. The large caps must show leadership and rally immediately -- or it will put at risk the critical and widely-anticipated year-end rally.
In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then offer up ...
Shares in Apple (Ticker: AAPL) are near their highs of the session in the final hour of trading on Wednesday, adding to the muted gains seen earlier in the day, following the release of the September FOMC meeting minutes and after activist investor and Apple shareholder Carl Icahn tweeted, “Tmrw we’ll be sending an open letter to @tim_cook. Believe it will be interesting.” Icahn’s tweet hit the ether at 2:33 pm ET and was met with a spike in volume in Apple shares. The stock is currently up 2.0% on the day at $100.75 as of 3:15 pm ET.
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither MaddJack Enterprises, LLC
d/b/a PhilStockWorld (PSW) nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.